0001209191-20-018979.txt : 20200313
0001209191-20-018979.hdr.sgml : 20200313
20200313172317
ACCESSION NUMBER: 0001209191-20-018979
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200312
FILED AS OF DATE: 20200313
DATE AS OF CHANGE: 20200313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cory David A
CENTRAL INDEX KEY: 0001670137
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 20714017
MAIL ADDRESS:
STREET 1: 350 CAMBRIDGE AVENUE, SUITE 350
CITY: PALO ALTO
STATE: CA
ZIP: 94306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-12
0
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001670137
Cory David A
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
1
1
0
0
President and CEO
Common Stock
2020-03-05
5
A
0
E
1500
7.31
A
69346
D
Stock Option (Right to Buy)
5.60
2020-03-12
4
A
0
230000
0.00
A
2030-03-11
Common Stock
230000
230000
D
These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
The option vests in equal monthly installments over 48 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date.
/s/ Sriram Ryali, Attorney-in-Fact
2020-03-13